Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated Tuberculosis
C. Garcia Vidal(University Hospital Mútua de Terrassa), Stéphanie Fernandez(University Hospital Mútua de Terrassa), J Lacasa(University Hospital Mútua de Terrassa), Miguel Salavert, Rafael Vidal(Universitat Autònoma de Barcelona), Mónica Rodríguez‐Carballeira(University Hospital Mútua de Terrassa), Javier Garau(University Hospital Mútua de Terrassa)
Cited by 178Open Access
Abstract
Six of 284 patients treated with infliximab developed active tuberculosis. Four (67%) of these patients had a paradoxical response to antituberculous therapy. Physicians should be aware of the increased risk of a paradoxical response in this population and should consider the use of corticosteroids when a paradoxical reaction is suspected.
Related Papers
No related papers found
Powered by citation graph analysis